Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Hemophilia and Trial Updates

The Hemophilia Channel on VJHemOnc is supported by BioMarin Pharmaceutical Inc. This supporter has no influence over the production of the content.

View overview page
5:18
HOPE-B: etranacogene dezaparvovec in adult hemophilia B
Wolfgang Miesbach • 25 May 2021
3:49
HOPE-B trial: etranacogene dezaparvovec shows promise in hemophilia B
Steven Pipe • 25 Nov 2020
4:57
A potential novel hemophilia treatment: an in vitro study of eptacog beta and emicizumab
Steven Pipe • 25 Nov 2020
3:29
Fitusiran prophylaxis shows encouraging results in hemophilia patients
Steven Pipe • 25 Nov 2020
3:57
First-in-human gene therapy study of BAY 2599023 in severe hemophilia A
Steven Pipe • 25 Nov 2020
The Hemophilia Channel on VJHemOnc is supported by BioMarin Pharmaceutical Inc. This supporter has no influence over the production of the content.

If you are interested in becoming a supporter of The Hemophilia Channel, please contact us

The content of VJHemOnc is intended for healthcare professionals